Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;224(1):121.
doi: 10.1016/j.ajog.2020.08.043. Epub 2020 Aug 21.

Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment

Affiliations
Comment

Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment

Lionel Carbillon et al. Am J Obstet Gynecol. 2021 Jan.
No abstract available

PubMed Disclaimer

Comment on

  • Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.
    Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, Choolani M, Mattar C, Su LL. Dashraath P, et al. Am J Obstet Gynecol. 2020 Jun;222(6):521-531. doi: 10.1016/j.ajog.2020.03.021. Epub 2020 Mar 23. Am J Obstet Gynecol. 2020. PMID: 32217113 Free PMC article. Review.

References

    1. Dashraath P., Wong J.L.J., Lim M.X.K. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222:521–531. - PMC - PubMed
    1. Karunajeewa H.A., Salman S., Mueller I. Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy. Antimicrob Agents Chemother. 2010;54:1186–1192. - PMC - PubMed
    1. Wang M., Cao R., Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269–271. - PMC - PubMed
    1. Balevic S.J., Green T.P., Clowse M.E.B., Eudy A.M., Schanberg L.E., Cohen-Wolkowiez M. Pharmacokinetics of hydroxychloroquine in pregnancies with rheumatic diseases. Clin Pharmacokinet. 2019;58:525–533. - PMC - PubMed
    1. Gautret P., Lagier J.C., Parola P. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56:105949. - PMC - PubMed